Wuhan Hvsen Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	5,253	1,660	2,364	3,356	4,735	4,413
Market Cap Growth	188.36%	-29.79%	-29.56%	-29.11%	7.30%	-
Enterprise Value	5,082	2,088	2,596	3,264	4,405	3,608
Last Close Price	26.06	9.97	14.04	19.45	26.69	24.74
PE Ratio	21.85	-	140.89	63.68	35.64	29.39
Forward PE	29.28	20.96	30.44	-	-	-
PS Ratio	3.15	1.38	2.32	3.28	4.75	5.68
PB Ratio	2.48	1.13	1.57	2.18	2.93	3.20
P/TBV Ratio	2.63	1.24	1.68	2.34	3.14	3.44
P/OCF Ratio	24.10	38.13	25.44	34.72	30.41	91.26
EV/Sales Ratio	3.05	1.74	2.55	3.19	4.42	4.64
EV/EBITDA Ratio	14.93	15.88	20.45	26.41	26.89	19.88
EV/EBIT Ratio	21.84	113.82	395.16	53.50	32.56	22.21
Debt / Equity Ratio	0.15	0.61	0.56	0.51	0.42	0.06
Debt / EBITDA Ratio	0.92	6.76	6.63	6.40	4.16	0.44
Net Debt / Equity Ratio	-0.09	0.25	0.16	0.00	-0.26	-0.51
Net Debt / EBITDA Ratio	-0.53	2.75	1.93	0.04	-2.55	-3.90
Net Debt / FCF Ratio	-1.49	-2.39	-2.67	-0.01	0.94	3.88
Asset Turnover	0.57	0.40	0.34	0.36	0.44	0.65
Inventory Turnover	4.88	4.22	3.78	3.72	4.06	4.92
Quick Ratio	1.32	1.08	1.25	1.42	2.70	3.03
Current Ratio	1.71	1.42	1.62	1.68	3.18	3.48
Return on Equity (ROE)	12.22%	-1.33%	1.10%	3.34%	8.86%	17.09%
Return on Assets (ROA)	4.95%	0.38%	0.14%	1.33%	3.76%	8.45%
Return on Invested Capital (ROIC)	10.62%	1.03%	0.40%	4.13%	12.73%	26.89%
Return on Capital Employed (ROCE)	10.50%	0.90%	0.30%	2.80%	6.00%	11.50%
Earnings Yield	4.10%	-1.21%	0.71%	1.57%	2.81%	3.40%
FCF Yield	2.31%	-9.09%	-3.87%	-9.90%	-9.39%	-4.14%
Dividend Yield	0.78%	1.07%	1.92%	1.54%	1.24%	1.10%
Payout Ratio	26.33%	-	349.40%	118.55%	36.08%	3.99%
Buyback Yield / Dilution	-8.54%	0.06%	-0.33%	0.19%	-12.59%	-18.45%
Total Shareholder Return	-7.76%	1.12%	1.59%	1.74%	-11.35%	-17.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.